ENCLEAR THERAPIES, INC.

Improving and extending lives of patients with CNS disease

Newburyport, United States · Founded 2024 · $21.0M raised

Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$21.0M
Last Round
$5.0M GrantSep 2024
Rounds
4

About

EnClear Therapies is a neurotechnology company developing the proprietary EnTrega CSF Platform for precision dosing and filtration of cerebrospinal fluid to treat CNS diseases including ALS, PSP, Alzheimer's, and neuro-oncology. The company has raised over $12M from investors including Dolby Family Ventures and Peter Thiel, and has received $5M+ in SBIR grants from the NIH NINDS and NCI.

Summary

ENCLEAR THERAPIES, INC. is a Biotech company based in Newburyport, United States, founded in 2024. It has raised $21.0M in total across 4 rounds, most recently a $5.0M Grant round in Sep 2024. Investors include National Cancer Institute, 20/20 HealthCare Partners and National Institute of Neurological Disorders and Stroke (NINDS).

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

GrantSep 2024
$5.0M

Sign up to see all 4 rounds

Seed through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ENCLEAR THERAPIES, INC. on Indexed.vc
<a href="https://indexed.vc/companies/enclear-therapies-inc"><img src="https://indexed.vc/api/badge/company/enclear-therapies-inc" alt="ENCLEAR THERAPIES, INC. on Indexed.vc" width="260" height="76" /></a>